FDA Inspection 1042100 — Fisher Clinical Services Inc.
The FDA completed an inspection of Fisher Clinical Services Inc. on January 10, 2018 in Mt Prospect, IL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- January 10, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Mt Prospect, IL (United States)